0
Signin
countryflagCA

888-969-2592

RY 156.04 -0.032% TD 79.81 -0.4615% SHOP 99.81 0.9303% CNR 158.79 0.6401% ENB 53.84 0.4478% CP 111.87 0.8019% BMO 112.71 0.7419% TRI 225.62 0.396% CNQ 50.46 2.4777% BN 67.8 1.194% ATD 76.93 -1.0674% CSU 4321.5298 0.3257% BNS 67.27 1.3102% CM 78.76 1.5603% SU 54.66 -1.1037% TRP 62.42 1.2162% NGT 70.54 0.2558% WCN 251.32 0.3153% MFC 36.65 -0.0818% BCE 47.21 0.3187%

KDA Group Inc

Healthcare CA KDA

0.265CAD
0.02(8.16%)

Last update at 2024-08-30T19:47:00Z

Day Range

0.240.27
LowHigh

52 Week Range

0.030.28
LowHigh

Fundamentals

  • Previous Close 0.24
  • Market Cap43.66M
  • Volume47530
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.62033M
  • Revenue TTM0.10M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 8.06M
  • Diluted EPS TTM-

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax 2.47M -4.64632M 0.34M -5.34693M -7.43793M
Minority interest - 0.00000M -0.00003M -0.66668M -0.41970M
Net income 16.14M -4.56233M 0.56M -4.30982M -8.51594M
Selling general administrative 3.11M 5.97M 5.07M 4.86M 5.48M
Selling and marketing expenses - - - - -
Gross profit 0.16M 8.06M 7.19M 5.86M 5.56M
Reconciled depreciation 0.57M 0.63M 0.48M 1.08M 0.58M
Ebit - 1.18M 1.43M 0.38M -0.05489M
Ebitda - -0.54451M 0.84M -1.46530M -4.34216M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -3.25666M 1.46M 1.64M -0.08078M -0.44161M
Other operating expenses - - - - -
Interest expense 1.39M 3.48M 0.01M 2.80M 2.52M
Tax provision 1.85M -0.08400M -0.54269M -0.79012M 0.88M
Interest income - - - - -
Net interest income -1.38943M -3.47663M -3.12343M -5.87378M -3.93845M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.08400M -0.54349M -0.79012M 0.88M
Total revenue 0.16M 28.82M 24.36M 22.89M 23.09M
Total operating expenses 3.42M 27.36M 22.72M 22.97M 23.54M
Cost of revenue 0.00000M 20.76M 17.17M 17.03M 17.54M
Total other income expense net 7.12M -2.63380M 1.83M 0.61M -3.05787M
Discontinued operations - - -0.32383M -0.55743M -0.53651M
Net income from continuing ops 0.62M -4.56233M 0.89M -4.55681M -8.32208M
Net income applicable to common shares - -4.56233M 0.56M -4.30982M -8.85859M
Preferred stock and other adjustments - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets 21.81M 28.67M 22.20M 19.91M 16.09M
Intangible assets 12.10M 10.16M 7.80M 1.96M 2.63M
Earning assets - - - - -
Other current assets - - 0.23M 4.03M -
Total liab 5.31M 28.87M 18.29M 23.57M 22.67M
Total stockholder equity 16.51M -0.20291M 3.91M -2.98804M -6.16075M
Deferred long term liab - 5.08M 2.44M - -
Other current liab - 1.78M 1.32M 1.72M 3.54M
Common stock - 29.90M 29.80M 25.09M 18.44M
Capital stock 30.26M 29.90M 29.80M 25.09M 18.44M
Retained earnings -16.83597M -32.60377M -28.04145M -28.60295M -24.09406M
Other liab - 0.27M 0.34M 3.19M 0.52M
Good will 0.00000M 6.31M 6.31M 6.31M 6.31M
Other assets - 7.49M 4.34M 0.99M 0.28M
Cash 4.63M 2.74M 1.72M 1.81M 1.23M
Cash and equivalents - - - - -
Total current liabilities 4.10M 22.44M 7.77M 10.02M 15.70M
Current deferred revenue - - - - -
Net debt - 10.07M 6.89M 4.12M 8.04M
Short term debt - - - - 8.80M
Short long term debt 1.60M 8.22M 2.73M 5.39M 8.80M
Short long term debt total - - - - -
Other stockholder equity - -0.37036M 0.50M -0.38647M -1.21934M
Property plant equipment - 1.90M 0.34M 0.42M 0.61M
Total current assets 6.65M 7.88M 5.85M 9.80M 5.56M
Long term investments 1.20M - - 0.70M 0.70M
Net tangible assets - -11.59631M -7.75729M -11.02274M -15.09762M
Short term investments - - - - -
Net receivables 0.46M 5.05M 3.75M 3.78M 4.23M
Long term debt - 4.59M 5.88M 0.53M 0.47M
Inventory - 0.00000M 0.06M 0.15M -
Accounts payable 1.76M 2.70M 2.06M 1.72M 2.49M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 10.53M
Deferred long term asset charges - - - - -
Non current assets total 15.16M 20.79M 16.35M 13.62M 10.53M
Capital lease obligations 1.56M 1.85M 0.25M 2.72M -
Long term debt total - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments 17.05M -2.68121M -3.10161M -1.12300M 2.52M
Change to liabilities - 1.73M 1.34M -0.41088M -2.59046M
Total cashflows from investing activities - -2.68121M -3.10161M -1.12300M 2.52M
Net borrowings - 2.26M -1.25239M -2.19332M -6.66458M
Total cash from financing activities -14.31471M 2.28M 0.09M 3.09M 0.09M
Change to operating activities - -0.39322M -0.60698M -0.02673M 0.24M
Net income 16.14M -4.56233M 0.56M -4.30982M -8.85859M
Change in cash 1.90M 1.02M -0.06508M 0.55M 0.26M
Begin period cash flow 2.74M 1.72M 1.81M 1.23M 0.97M
End period cash flow 4.63M 2.74M 1.72M 1.81M 1.23M
Total cash from operating activities -0.84402M 1.42M 2.94M -1.41701M -2.35111M
Issuance of capital stock - 0.00000M 1.20M 4.18M 6.76M
Depreciation 0.57M 0.62M 0.48M 0.83M 0.52M
Other cashflows from investing activities - -0.05260M -0.60227M -0.79245M 3.80M
Dividends paid - - - - -
Change to inventory 0.00000M 0.00000M 0.04M -0.14991M 1.52M
Change to account receivables -2.18998M -1.31851M -0.05665M -0.39127M -0.21609M
Sale purchase of stock -1.48010M - - - -
Other cashflows from financing activities - - 0.13M 0.84M 0.84M
Change to netincome - 6.24M 1.16M 3.33M 6.98M
Capital expenditures 2.13M 0.05M 0.05M 0.10M 0.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.69946M -0.88455M 0.74M 0.70M -1.11872M
Stock based compensation 0.21M 0.28M 0.88M 0.35M 0.33M
Other non cash items -9.56131M 2.90M -3.98582M 2.62M 2.65M
Free cash flow -2.97539M -1.21188M 0.44M -2.34737M -3.02535M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
KDA
KDA Group Inc		 0.02 8.16% 0.27 - - 458.88 2.87 461.75 11.09
PHA
Premier Health of America Inc		 -0.01 5.88% 0.16 - 37.04 0.27 1.48 0.56 8.61
NLH
Nova Leap Health Corp		 -0.02 7.69% 0.24 - 6.14 0.78 0.82 0.84 -129.1199
NPTH
NeuPath Health Inc		 0.005 2.86% 0.18 - 6.64 0.15 0.44 0.29 9.33
JNH
Jack Nathan Medical Corp		 -0.01 25.00% 0.03 - - 0.25 7.84 0.61 -1.8458

Reports Covered

Stock Research & News

View All

Profile

KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services. The company also offers PREDICTIVE e-Prescriber software for assisting doctors; and KRx, a cloud-based solution that analyzes each user's prescription pattern and displays the appropriate expected medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. was founded in 2009 and is headquartered in Thetford Mines, Canada.

KDA Group Inc

1351, Notre Dame St. East, Thetford Mines, QC, Canada, G6G 0G5

Key Executives

Name Title Year Born
Mr. Marc Lemieux Co-Founder, Chairman, CEO & Pres NA
Ms. Isabelle Begin Co-Founder, Exec. VP of Pharmacy Services Division & Director NA
Mr. Jean-Pierre Robert B.Sc. Chief Operating Officer NA
Mr. Pierre Monet Sec. NA
Mr. Luc Olivier Chief Financial Officer NA
Dr. Giuseppe D'Aprano Chief Scientific Officer NA
Ms. Annie Mercier Controller NA
Mr. Jean-Marc Leveille Member of Strategic Advisory Board and Consultant of HR & Strategic Planning NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.